Mensifem (Dry Extract From Cimicifuga Racemosa (L.) Nutt., Rhizoma (Black Cohosh) (5-10:1), Extraction Solvent)

The dry extract of Cimicifuga racemosa is believed to modulate serotonergic pathways and may exhibit weak estrogenic activity, which together influence the hypothalamic centers that regulate body temperature and mood, thereby reducing vasomotor and emotional symptoms associated with menopause.

The appropriate dose of Mensifem is determined by the prescribing healthcare professional based on individual needs, product formulation, and local regulatory guidance. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Mensifem is not recommended for use during pregnancy or while breastfeeding unless a qualified healthcare provider explicitly advises otherwise. The safety profile for these populations has not been established, and alternative therapies should be considered.

To order Mensifem, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Mensifem offers a plant‑based, non‑hormonal option for menopausal symptom relief, whereas conventional hormone replacement therapy provides estrogen or progesterone supplementation. Compared with other herbal remedies, Mensifem uses a standardized black cohosh extract, which may provide more consistent efficacy while maintaining a favorable safety profile.

Mensifem should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and excessive heat to maintain its potency and stability throughout its shelf life.

Mensifem is taken orally, typically with water. The exact administration schedule—such as frequency and timing relative to meals—should be directed by the prescribing clinician, who will tailor the regimen to the patient’s individual therapeutic needs.

Serious but rare risks include liver enzyme elevation, severe allergic reactions such as anaphylaxis, and significant hypotension. Patients should seek immediate medical attention if they experience signs of liver dysfunction, widespread rash, swelling, or sudden drops in blood pressure.

Mensifem should be avoided by individuals with known hypersensitivity to black cohosh, those with active liver disease, pregnant or nursing women unless advised by a physician, and patients taking medications that may interact severely, such as anticoagulants or certain serotonergic agents.